Skip to main content
. 2021 Jul 6;25(11):1231–1239. doi: 10.1007/s10157-021-02100-0

Table 7.

Occurrence of adverse drug reactions by safety specification category

Safety specifications Number of patients
Preferred term
Acute hepatic failure and hepatic function disorder 226
 Acute hepatic failure 1
 Alanine aminotransferase abnormal 1
 Alanine aminotransferase increased 9
 Aspartate aminotransferase abnormal 1
 Aspartate aminotransferase increased 11
 Gamma-glutamyltransferase increased 15
 Hepatic function abnormal 136
 Hepatic steatosis 1
 Hepatitis acute 1
 Hyperbilirubinaemia 2
 Liver disorder 50
 Liver function test abnormal 2
 Transaminases increased 1
 Hepatic enzyme increased 11
 Drug-induced liver injury 5
 Hepatic cancer 1
 Liver function test increased 3
Thirst 133
 Lip dry 1
 Thirst 133
Hypernatraemia 81
 Blood sodium increased 7
 Hypernatraemia 74
Renal failure and impairment 80
 Azotaemia 0
 Blood creatinine increased 18
 Blood urea increased 14
 Glomerular filtration rate decreased 2
 Renal disorder 2
 Renal failure 11
 Protein urine present 1
 Postrenal failure 1
 Renal impairment 36
 Chronic kidney disease 3
 Acute kidney injury 3
 Prerenal failure 2
 End stage renal disease 1
Hyperkalaemia 23
 Blood potassium increased 4
 Hyperkalaemia 13
 Muscle spasms 6
Dehydration 17
 Dehydration 16
 Weight decreased 2
Thrombosis and thromboembolism 7
 Cerebellar infarction 1
 Cerebral infarction 2
 Disseminated intravascular coagulation 1
 Pulmonary embolism 2
 Retinal artery occlusion 1